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Conclusions: Serial PW-TDI and annual EBCT are reliable for timing of cardiac catheter- 
izations. Thy can facilitate the early diagnosis of coronary stenoses or its aggravation, 
before the appearance of regional wall motion disturbances or alteration of the LV ejec- 
tion fractton. 
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855-3 Dobutamine Stress Echocardiography Is Predictive of 
Events After Heart Transplantation 
Matthew Pincus, Tuan Nguyen, Anne Keogh, Christopher S. Hayward, Michael Fen&y. 
Peter Macdonald. St. Vincent’s Hospital, Sydney, Australia, Galvan Institute of MedIcal 
Research, Sydney, Australia 
Background: Cardiac allograft vasculopathy (CAV) is the commonest cause of death in 
patients surviving more than one year after heart transplantation. Non-invasive diagnosis 
is made difficult by the absence of angina in most cases, the insensitivity of scintigraphy, 
and a diminished exercise response. Dobutamine stress echocardiography (DSE) has 
been shown to have good sensitivity relative to angiography and has become a com- 
monly used non-invasive screening tool for CAV There is less published information on 
the prognostic value of DSE in transplant recipients, although a study of 109 patients 
found it to be predictive of cardiac events. The aim of this study was to assess the predic- 
tive value of DSE in a larger patient population. 
Methods: A retrospective study was made of 240 heart transplant recipients referred for 
screening DSE. Dobutamine infusion rate was started at 5mcg/kg/min and increased to a 
maximum of 50 mcglkglmin or maximum predicted heart rate. The definitions of an 
abnormal resting and stress study were. respectively, a resting regional wall motion 
abnormality and a new or worsening regional wall motion abnormality with dobutamine. 
The primary endpoint was a combination of the following events: death, acute coronary 
syndrome, heart failure, percutaneous coronary intervention and coronary bypass sur- 
gery. 
Results: 455 DSE examinations were performed with each patient having between one 
and five. The mean followup period was 3.5 years (range 1 month-7 years). 53 patients 
had a total of 66 events. The odds ratios of an event for any abnormality on DSE, a rest- 
ing abnormality, and a stress abnormality were 3.1(95%Cl l&7.1), 3.2 (1.3-6.4) and 3.6 
(1.4-9.5) respectively. The probability of being event free at 1 yearwas 95% in those with 
a normal DSE. The probability of having an event at 2 years was 10% in those with a nor- 
mal and 32% in those with an abnormal DSE and this was significantly different (pcO.05). 
Conclusions: DSE is predictive of events after heart transplantation. A normal DSE iden- 
tifles patients at low risk of an event over the subsequent 12 months. In screening for 
CAV, invasive studies such as angiography could reasonably be restricted to those who 
have an abnormal DSE. 
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855-4 Transcriptional Profiling of the Vascular Smooth Muscle 
Cell Response to Allograft Injury 
Michael V. Autieri, Sheri E. Kelemen, Howard J. Eisen, Temple University School of 
Medicine, Philadelphia, PA 
BACKGROUND: The activation of Vascular Smooth Muscle Cells (VSMC) is responsible 
for most of the obliterative arterial intimal thickening present in cardiac allograft vasculop- 
athy (CAV). Characterization of proteins which regulate VSMC activation in response to 
vascular injury is an important approach to understanding the process leadmg to CAV 
formation. 
METHODS: Pnmary human coronary artery VSMC were challenged with T lymphocyte 
conditioned media in the presence and absence of the immunosuppressive compounds 
cyclosporin A (CsA). mycophenollc acid (MA), and rapamycin (R), and the temporal pro- 
gram of gene expression was Investigated by cDNA microarray analysis representing 
60,000 sequences. The expression of several candidate proteins were investigated fur- 
ther by western blot and immunohistochemistry on normal, failing, and 
transplanted human coronary arteries. RESULTS: Fold-change analysis revealed that 
inflammation-induced transcripts could be clustered Into several categories based on 
their temporal pattern of expression. These included cytokine, cell cycle, cytoskeletal, 
and remodeling proteins. Additional clusters could be identified by their common or differ- 
ing inhibition to CsA, MA, and/or R. The expression of one representatrve gene. the tran- 
scription factor Forkhead Activin Signal Transducer-l (FAST-l), was upregulated in 
activated VSMC but inhibited by CsA, MA, and R. FAST-l is a 
transcriptional regulator of TGF? signaling, and plays a role in tumorigenesis and mainte- 
nance of differentiated cell states. Western blots confirm increased FAST-l expression in 
arteries with CAV versus normal and arteries from failing hearts. lmmunohistochemical 
analysis determined that forkhead expression localized to medial and neointimal VSMC, 
and infiltrating leukocytes in these vessels. CONCLUSIONS: These results demonstrate 
differential gene expresslon in the VSMC response to inflammatory stimuli and immuno- 
suppressive regimens, and suggest that the transcription factor FAST-1 may participate 
in the VSMC response to injury and may represent important molecular targets of anti- 
restenotic therapy. 
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855-5 Elevsted Interleukin-1 Levels, Nuclear Factor KB 
Activation, and Arterial Intercellular Adhesion Molecule- 
1 Expression Are Associated With Development of 
Transplant Coronary Artery Disease 
Carlos A. Labarrere. Rodney W. Benner, Steven J. Miller, Edward J. Brizendine. Joshua 
B. Lee, Douglas E. Pitts. David A. Hormuth, Methodist Research Institute at Clarian 
Health, Indianapolis, IN, Indiana University School of Medicine, Indianapolis, IN 
Background: Intercellular adhesion molecule-l (ICAM-1) on arterial endothellum and in 
circulation are implicated in the development of transplant coronary artery disease 
(CAD). We studied the relationships among interleukin-16 (IL-l& which stimulates 
ICAM-1; nuclear factor & (NFrB); ICAM-1; and subsequent CAD. Methods: Using a 
sandwich ELISA we measured IL-16 and ICAM- in a median of 6 serial serum samples 
obtained during the first 3 months post-transplantation from 139 heart transplant patients. 
The median IL-16 value over the serial samples was estimated and subsequently classi- 
fied as low, moderate or high levels, based on the distribution quartiles. Matching 
endomyocardial biopsies were studied immunohistochemically for IL-IO, NFKB and 
ICAM-1. Yearly senal coronary angiograms (median: Z/patient) were assessed for CAD. 
Results A significant association was found between IL-16 levels and subsequent 
development of transplant CAD (p=O.Ol). Patients with increased IL-16 levels developed 
more severe disease (p=O.O2). A significant association was found between increased 
IL-16 and ICAM- levels in the biopsies (p=O.O2) and in circulation (p<O.Ol). IL-16 was 
found in macrophages and endothelium of biopsies from patients with high soluble levels 
but not in biopsies from patients with low levels. NFrB was localized in endothellal nuclei 
of patients with high IL-10 levels but not I” those with low levels. Conclusion: Elevated 
soluble IL-1 I3 levels during the first 3 months after transplantation are associated with (a) 
endothelial IL-16 expresslon and NFrB nuclear localization within the allografts, (b) ele- 
vated levels of tissue-associated and soluble ICAM-1, and (c) subsequent development 
of transplant CAD. Endothelial activation within the allografts could be mediated by IL-10 
expression and NFKB translocation, and this can result in development of transplant 
CAD. 
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1208-70 lntrathoracic Impedance: A Surrogate Measure of Fluid 
Retention and Predictor of Hospitalization in Patients 
With Heart Failure 
Cheuk-Man Yu. Elaine Chau, Chu-Pak Lau, Wal-Fat Lam, Man-Oi Tang, Shun-Lmg 
Kona. Qina Zhana. Hona Lin. Jill Christensen. Macrina Wona. Jennv Fona, LI Wana. The _ _ _ ” _,- - 
Chinese University of Hong Kong, Hong Kong, Hong Kong, Medtronic Inc., Minneapolis, 
MN 
Background: A significant portion of patients implanted with pacemaker or ICD has con- 
gestive heart failure (CHF). The ability of an implantable device to better monitor fluid 
status and provide early warnings of fluid overload may help prevent CHF hospitalization. 
As fluid accumulates in the lung, intra-thoracic impedance (Z) is decreased. This study 
investigated the feasibility of using the Z sensor to measure pulmonary congestion and 
predict CHF admission. Methods: A special pacemaker and an ICD lead were implanted 
in 32 CHF patients with NYHA class Ill-IV. A download-software was used for Z mea- 
surement (between the RV electrodes and pacemaker can) and storage. Z was stored in 
the pacemaker 4 times/day during chronic monitonng and every 30 minutes during CHF 
hospitalization where pulmonary capillary wedge pressure (PCWP) measurement was 
performed, and the fluid status of the patients was carefully monitored. The maximum 
changes of Z and PCWP, and the net fluid inputioutput (FIO), withln 6 hours after Intrave- 
nous diuretics, were calculated and averaged. Results: With a mean follow-up of 6.4*4.6 
months, 9 patients developed 20 episodes of CHF hospitalizations. Over 2.Oil.2 weeks 
(5 days to 4 wks) prior to CHF admlssion, Z reduced 14*7% (p<O.OOOl) from the relative 
“baseline”. The 2-3 days of intravenous diuretic therapy resulted in a mean PCWP reduc- 
tion of 21*9 mmHg (~~0.02) with a corresponding Z increase of 20rlO% (PcO.001). Z 
increase correlated well with PCWP reduction (r=-0.7, pcO.001) and with FIO (r=-0.95, 
p=O.O003). The average reduction of PCWP within 6 hours of intravenous diuretic ther- 
apy was 3.5+4.7mmHg (p=O.O3), while Z increased by 6+4.5% (pcO.01) and FIO was - 
656+560 ml (p=O.O2). Conclusion: Device-based Z started to decrease with a mean 
reduction of 14% 2 weeks prior to CHF admission. The good correlation between 2 and 
PCWP as well as volume status suggests that Z may be a surrogate measure of pulmo- 
nary congestion/edema in CHF patients. In patients with pacemakers or ICD, the intra- 
thoracic 2 sensor may provide a chronic diagnostic indicator of patient fluid status, and 
an early prediction of CHF admission. 
